A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China

References

• SolomkinJSMazuskiJEBradleyJSDiagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of AmericaClin Infect Dis201050213316420034345
   PubMed Web of Science ®Google Scholar
• SartelliMCatenaFAnsaloniLComplicated intra-abdominal infections worldwide: the definitive data of the CIAOW StudyWorld J Emerg Surg201493724883079
   PubMed Web of Science ®Google Scholar
• KurupALiauKHRenJAntibiotic management of complicated intra-abdominal infections in adults: The Asian perspectiveAnn Med Surg2014338591
   PubMedGoogle Scholar
• MikamoHYuasaAWadaKCrawfordBSugimotoNOptimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With MetronidazoleOpen Forum Infect Dis201633ofw14327704002
   PubMed Web of Science ®Google Scholar
• OuyangWXueHChenYClinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern ChinaInt J Antimicrob Agents201647321021626899413
   PubMed Web of Science ®Google Scholar
• BaqueroFHsuehP-RPatersonDLIn vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART)Surg Infect200910299104
   Web of Science ®Google Scholar
• HsuehPRStudy for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002–2010Int J Antimicrob Agents201240SupplS1S322749052
   PubMed Web of Science ®Google Scholar
• YangQZhangHWangYA 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in ChinaJ Med Microbiol201362Pt 91343134923741022
   PubMed Web of Science ®Google Scholar
• JeanSSHsuehPRSMART Asia-Pacific GroupDistribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008–14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)J Antimicrob Chemother201772116617127703058
   PubMed Web of Science ®Google Scholar
• PfizerTygacil® U.S. Physician Prescribing Information Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021821s039lbl.pdfAccessed 29 July, 2018
   Google Scholar
• FominPBeuranMGradauskasATigecycline is efficacious in the treatment of complicated intra-abdominal infectionsInt J Surg200531354717462257
   PubMedGoogle Scholar
• TowfighSPasternakJPoirierALeisterHBabinchakTA multi-centre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infectionsClin Microbiol Infect20101681274128120670293
   PubMed Web of Science ®Google Scholar
• QvistNWarrenBLeister-TebbeHEfficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trialSurg Infect2012132102109
   Web of Science ®Google Scholar
• ChenZWuJZhangYEfficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trialBMC Infect Dis20101021720663130
   PubMed Web of Science ®Google Scholar
• Pfizer ChinaTygacil® China Physician Prescribing Information Available from: https://www.pfizermedicalinformation.cn/OpenDocument.aspx?DocumentID=73c20343-2116-4078-910a-ab9fc4f6e6ea&Type=PackageInsertsAccessed 29 July, 2018
   Google Scholar
• United States FDA Tygacil® (tigecycline) label information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021821s026s031lbl.pdfAccessed 29 July, 2018
   Google Scholar
• FleissJLStatistical Methods for Rates and Proportions2nd edNew YorkJohn Wiley & Sons19812930
   Google Scholar
• ClopperCJPearsonESThe use of confidence or fiducial limits illustrated in the case of the binomialBiometrika1934264404413
   Google Scholar
• NewcombeRGInterval estimation for the difference between independent proportions: comparison of eleven methodsStat Med19981788738909595617
   PubMed Web of Science ®Google Scholar
• WilsonEBProbable inference, the law of succession, and statistical inferenceJ Am Stat Assoc192722158209212
   Google Scholar
• NewcombeRGTwo-sided confidence intervals for the single proportion: comparison of seven methodsStat Med19981788578729595616
   PubMed Web of Science ®Google Scholar
• OlivaMERekhaAYellinAA multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]BMC Infect Dis200558816236177
   PubMed Web of Science ®Google Scholar
• BabinchakTEllis-GrosseEDartoisNThe efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial dataClin Infect Dis200541Suppl 5S354S36716080073
   PubMed Web of Science ®Google Scholar
• GiammancoACalàCFascianaTDowzickyMJGlobal Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance TrialmSphere201721e00310e0031628124025
   PubMed Web of Science ®Google Scholar
• BassettiMMcGovernPCWenischCClinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trialsInt J Antimicrob Agents201546334635026155003
   PubMed Web of Science ®Google Scholar
• MazuskiJETessierJMMayAKThe Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal InfectionSurg Infect2017181176
   PubMed Web of Science ®Google Scholar